Data updated: Mar 29, 2026
VALTURNA
ALISKIREN HEMIFUMARATE
Approved 2009-09-16
1
Indication
--
Phase 3 Trials
16
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2009-09-16
- Routes
- ORAL
- Dosage Forms
- TABLET
VALTURNA Approval History
Loading approval history...
What VALTURNA Treats
1 FDA approvalsOriginally approved for its first indication in 2009 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
VALTURNA FDA Label Details
ProVALTURNA Patents & Exclusivity
Latest Patent: Jul 2026
Patents (4 active)
US8168616
Expires Jul 3, 2026
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.